Measurements of serum from SPG11–HSP patients (n = 13) compared to matched controls (n = 20) showed increased levels of the proinflammatory cytokine IL-6, while levels of additional cytokines were unchanged (Fig. 3c). The gene discussed is IL6; the disease is hereditary spastic paraplegia.